With a manufacturing capacity of 150 MT per month, we provide premium granules for pharmaceutical formulations. Our granules come in profiles such as Sustained Release, Taste Masked (TM), and Immediate Release, including products like Tadalafil Granules, Ibuprofen Granules, and Azithromycin Granules.
We collaborated with five Hyderabad-based granules manufacturing companies, which together have a monthly capacity of 150 MT.
SR
TM
IR
| S.No | Product Name | S.No | Product Name |
|---|---|---|---|
| 1 | Tadalafil Granules | 2 | Aripiprazole Granules |
| 3 | Azithromycin Granules | 4 | Bisoprolol fumarate Granules |
| 5 | Celecoxib Granules | 6 | Ciprofloxacin Granules |
| 7 | Clarithromycin Granules | 8 | Escitalopram Granules |
| 9 | Etoricoxib Granules | 10 | Famotidine GR Granules |
| 11 | Fexofenadine DC Granules | 12 | Flurbiprofen DC Granules |
| 13 | Fluvastatin DC Granules | 14 | Gliclazide Granules |
| 15 | Ibuprofen Granules | 16 | Paracetamol Granules |
| 17 | Levetiracetam DC Granules | 18 | Montelukast Granules |
| 19 | Racecadotril Granules | 20 | Risperidone Granules |
| 21 | Silodosin Granules | 22 | Tolterodine Granules |
| 23 | Valsartan Granules | 24 | Valproicacid Granules |
| No. | Active Ingredient | Concentrations | Source |
|---|---|---|---|
| 1 | AMLODIPINE | 3.33%, 6.66% | In-House |
| 2 | ARIPIPRAZOLE | 4.3%, 5%, 8.33%, 10%, 15% | In-House |
| 3 | ASCORBIC ACID | 90% | USP |
| 4 | ASPIRIN | 50%, 90% | USP |
| 5 | ATORVASTATIN | 10%, 20% | In-House |
| 6 | AZITHROMYCIN | 7.5% TM, 65.27% DC | In-House |
| 7 | BETAHISTINE | 12% | In-House |
| 8 | BISOPROLOL FUMARATE | 4%, 8% | In-House |
| 9 | CANDESARTAN CILEXETIL | 4.0% | In-House |
| 10 | CARBAMAZEPINE | 50% | In-House |
| 11 | CELECOXIB | 37%, 74%, 80% | In-House |
| 12 | CIPROFLOXACIN | 20%, 65%, 75% | In-House |
| 13 | CLARITHROMYCIN | 7.5%, 27.5%, 42%, 62.5% | In-House |
| 14 | CLOPIDOGREL | 50% | In-House |
| 15 | COTRIMOXAZOLE | 93% | In-House |
| 16 | DICLOFENAC POTASSIUM | 20% | In-House |
| 17 | DIGOXIN | 0.2% | USP |
| 18 | DONEPEZIL HCL | 3.57% | USP |
| 19 | DOXAZOSIN | 2% | USP & BP/EP |
| 20 | DRIED FERROUS SULPHATE | 77% | USP & BP/EP |
| 21 | ESCITALOPRAM | 10% | In-House |
| 22 | ESOMEPRAZOLE | 15% | USP |
| 23 | ETORICOXIB | 50% | USP |
| 24 | FAMOTIDINE | 16% | In-House |
| 25 | FEXOFENADINE | 50% | In-House |
| 26 | FINASTERIDE | 4% | USP & BP/EP |
| 27 | FLURBIPROFEN | 53% | In-House |
| 28 | FLUVASTATIN SODIUM | 25% | USP & BP/EP |
| 29 | GEMFIBROZIL | 70% | USP & BP/EP |
| 30 | GLIBENCLAMIDE | 4% | BP/EP |
| 31 | GLICLAZIDE | 20% | BP/EP |
| 32 | GLUCOSAMINE | 25% | In-House |
| 33 | HYDROCHLOROTHIAZIDE | 4.17% | In-House |
| 34 | IBUPROFEN | 6.7%, 66%, 90% | In-House |
| 35 | INDAPAMIDE SR | 0.77% | In-House |
| 36 | IRBESARTAN | 50% | USP |
| 37 | LAMIVUDINE | 13.5% | USP |
| 38 | LAMOTRIGINE | 12% | USP |
| 39 | LEVETIRACETAM | 62.5% | USP |
| 40 | LEVOCETRIZINE DI HCL | 2.5%, 10% | In-House |
| 41 | LEVOFLOXACIN | 60% | In-House |
| 42 | LINEZOLID | 20% | In-House |
| 43 | LOPERAMIDE HYDROCHLORIDE | 1% | In-House |
| 44 | MEBEVERINE HCL | 20% | In-House |
| 45 | MESALAZINE | 54.11%, 66.66% | USP |
| 46 | METFORMIN SR | 70%, 77% | USP |
| 47 | METFORMIN HYDROCHLORIDE SR | 66.66%, 78.12%, 90%, 95% | In-House |
| 48 | METOPROLOL SUCCINATE | 10%, 20%, 25%, 50% | In-House |
| 49 | METOPROLOL TARTRATE | 29.5% DC, 50% ER | In-House |
| 50 | MONTELEUKAST | 0.4%, 4.0% | In-House |
| 51 | MOXIFLOXACIN | 57.15% | In-House |
| 52 | NAPROXEN SODIUM | 73.34%, 80%, 90% | In-House |
| 53 | OLANZAPINE | 5% | In-House |
| 54 | OLMESARTAN MEDOXOMIL | 13.33% | In-House |
| 55 | |||
| 56 | PARACETAMOL (ACETAMINOPHEN) | 12%, 65%, 90% | In-House |
| 57 | PAROXETINE | 10% | In-House |
| 58 | PREGABALIN | 25%, 75% | In-House |
| 59 | RABEPRAZOLE SODIUM | 15% | In-House |
| 60 | RACECADOTRIL | 1%, 3% | In-House |
| 61 | RISPERIDONE | 0.33%, 1.33%, 2%, 3% | In-House |
| 62 | ROSUVASTATIN | 4.16%, 10%, 13.33% | In-House |
| 63 | SERATRODAST | 20%, 50% | In-House |
| 64 | SILDENAFIL CITRATE | 20% | In-House |
| 65 | SILODOSIN | 2% | In-House |
| 66 | SIROLIMUS | 0.4%, 0.8%, 1.6% | In-House |
| 67 | SITAGLIPTIN PHOSPHATE | 40% | In-House |
| 68 | SOLIFENACIN SUCCINATE | 5% | In-House |
| 69 | TADALAFIL | 1%, 2%, 5%, 6.67% | In-House |
| 70 | TELMISARTAN | 11.76% | In-House |
| 71 | TERAZOSIN | 2% | In-House |
| 72 | TIZANIDINE | 2% | In-House |
| 73 | TOLPERISONE HCL | 60% | In-House |
| 74 | TOLTERODINE TARTRATE | 2% | In-House |
| 75 | TRIMEBUTINE | 0.787% | In-House |
| 76 | URSODEXICHOLIC ACID | 70% | In-House |
| 77 | VALPROIC ACID | 52.06% | In-House |
| 78 | VALSARTAN | 50% | In-House |
| S.No | Name of the Product | Reference |
|---|---|---|
| 01 | Amlodipine 2.12% and Valsartan 48.78% Granules | In-House |
| 02 | Amlodipine 4.15% and Valsartan 48% Granules | In-House |
| 03 | Aspirin 11.33% and Clopidogrel 11.33% DC Granules | In-House |
| 04 | Candesartan 12.31% + Hydrochlorothiazide 9.62% DC Granules | In-House |
| 05 | Ezetimibe 2% + Atorvastatin 4% DC Granules | In-House |
| 06 | Ezetimibe 4% + Atorvastatin 4% DC Granules | In-House |
| 07 | Irbesartan 50% and Hydrochlorothiazide 2.08% Granules | In-House |
| 08 | Irbesartan 50% and Hydrochlorothiazide 4.16% Granules | In-House |
| 09 | Lamivudine + Zidovudine + Abacavtr (13.5% + 27.27% + 27.27% DC Granules) | In-House |
| 10 | Olmesartan Medoxomil 13.33% and Amlodipine 1.67% | In-House |
| 11 | Olmesartan Medoxomil 13.33% and Amlodipine 1.67% Granules | In-House |
| 12 | Olmesartan Medoxomil 13.33% and Amlodipine 1.67% Granules | In-House |
| 13 | Olmesartan Medoxomil 13.33% and Amlodipine 3.34% Granules | In-House |
| 14 | Olmesartan Medoxomil 13.33% and Hydrochlorothiazide 4.17% Granules | In-House |
| 15 | Olmesartan Medoxomil 13.33% and Hydrochlorothiazide 8.33% Granules | In-House |
| 16 | Perindopril 4% and Indapamide 1.25% DC Granules | In-House |
| 17 | Perindopril 5% and Indapamide 1.25% DC Granules | In-House |
| 18 | Rosuvastatin 4% & Ezetimibe 4% DC Granules | In-House |
| 19 | Telmisartan 11.76% + Hydrochlorothiazide 1.84% DC Granules | In-House |
| 20 | Telmisartan 23.53% and Hydrochlorothiazide 3.68% Granules | In-House |
| 21 | Telmisartan 23.53% and Hydrochlorothiazide 7.36 % Granules | In-House |
| 22 | Telmisartan 23.53% Granules | In-House |
| 23 | Telmisartan 23.53%& Amlodipine 3.68% DC Granules | In-House |
| 24 | Telmisartan 9.08% + Hydrochlorothiazide 2.84% DC Granules | In-House |
| 25 | Tramadol Hydrochloride 6.91% + Paracetamol 60% DC Granules | In-House |
| 26 | Tramadol Hydrochloride 8.33%+ Paracetamol 72.22% DC Granules | In-House |